U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07441083) titled 'Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness' on Feb. 23.
Brief Summary: This randomized, double-blind, placebo-controlled clinical study is designed to evaluate the efficacy and safety of a standardized Shatavari (Asparagus racemosus) root extract (SRI-81) in improving women's sexual wellness. Sexual wellness is assessed as a multidimensional construct encompassing sexual function, sexual distress, sexual satisfaction, perceived stress, quality of life, and physiological stress markers. Participants will receive either Shatavari root extract or placebo for 12 weeks, with assessments conducted at baseline...